The Longevity Science Foundation (LSF) reports that the use of psychedelics for mental health treatments is gaining momentum at an unprecedented pace. Compounds such as MDMA, ketamine, and psilocybin have demonstrated encouraging outcomes in treating PTSD, depression, and addiction. In addition, researchers have shown that ketamine and psilocybin may assist in regenerating neural connections, which could have far-reaching implications in the development of treatments for neurodegenerative disorders associated with aging, as per the LSF.
Republican Senators James Lankford (Oklahoma) and Pete Ricketts (Nebraska) have introduced a bill that seeks…
New blue hues and flavors from top breeders have arrived. The post New Blueberry weed…
While there are many studies showing potential and promise for using various compounds in cannabis…
Trump's declaration of drug cartels as terrorist organizations and his war cry to ramp up…
A recent poll conducted by the University of Houston’s Hobby School of Public Affairs has…
Candies, Z, OGs, and more from Leafly’s senior editor. The post David Downs’ sickest weed…